Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 3, 2003 - Issue 3
Submit an article Journal homepage
27
Views
10
CrossRef citations to date
0
Altmetric
Review

Epidemiology, treatment and costs of depression in adults with Type 2 diabetes

Leonard E Egedeand Department of Medicine and Center for Healthcare Research, Medical University of South Carolina, Center for Healthcare Research, 135 Cannon Street, Suite 403, PO Box 250837, Charleston, SC 29425 USA
&
Kit Simpson Department of Medicine and Center for Healthcare Research, Medical University of South Carolina, Center for Healthcare Research, 135 Cannon Street, Suite 403, PO Box 250837, Charleston, SC 29425 USA
Pages 251-262 | Published online: 09 Jan 2014

References

  • Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 26\(Suppl. 1), S5—S20 (2003).
  • Goldstein BJ. Insulin resistance as the core defect in Type 2 diabetes mellitus. Am. j Carcliol 90(5A), G3—G10 (2002).
  • American Diabetes Association. Screening for Type 2 diabetes. Diabetes Care 26(Suppl.) 1, S21—S24 (2003).
  • Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAIVIA 285(19), 2486–2497 (2001).
  • Regier DA, Narrow WE, Rae DS, Manderscheid RVV, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry50(2), 85–94 (1993).
  • •Data on prevalence of mental disorders in the USA.
  • Narrow WE. One-year prevalence of depressive disorders among adults 18 and over in the US: NIMH ECA prospective data. Population estimates based on US Census estimated residential population age 18 and over on July 1,1998. (Unpublished).
  • Carta MG, Carpiniello B, Kovess V, Porcedda R, Zedda A, Rudas N. Lifetime prevalence of major depression and dysthymia: results of a community survey in Sardinia. Eur. Neuropsychopharmacol. 5 (Suppl), 103–107 (1995).
  • Lepine JP, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int. Clin. Psychopharmacol. 12(1), 19–29 (1997).
  • Hemels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981–2000. Ann. Pharmacother. 36(9), 1375–1379 (2002).
  • McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J, Auland ME. Recent trends in the use of antidepressant drugs in Australia, 1990— 1998. Med. j Aust. 173(9), 458–461 (2000).
  • US Department of Health and Human Services. Mental Health: A Report of the Surgeon General. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, Rockville, MD, USA (1999).
  • ••Provides detailed information about thepidemiology and pathophysiology of mental illnesses in the USA.
  • Weissman MM, Bland RC, Canino GJ et al Prevalence of suicide ideation and suicide attempts in nine countries. Psychological Med. 29(1), 9–17 (1999).
  • American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disarlers, (Fourth Edition) (DSM-IV). American Psychiatric Press, Washington DC, USA (1994).
  • Michaud CM, Murray CJ, Bloom BR. Burden of disease-implications for future research. JAIVIA 285(5), 535–539 (2001).
  • Zheng D, Macera CA, Croft JB, Giles WH, Davis D, Scott WK. Major depression and all-cause mortality among white adults in the United States. Ann. Epidemiol. 7(3), 213–218 (1997).
  • Bruce ML, Leaf PJ, Rozal GP, Florio L, Hoff RA. Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am. PTchiatry151 (5), 716–721 (1994).
  • Penninx BW, Geerlings SW Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT Minor and major depression and the risk of death in older persons. Arch. Gen Psychiatry56(10), 889–895 (1999).
  • Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6), 1069–1078 (2001).
  • ••Important study that provides reliableestimates of the odds of depression in individuals with diabetes.
  • Egede LE, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 26(1), 104–111 (2003).
  • Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased healthcare use and expenditures in individuals with diabetes. Diabetes Care 25(3), 464–470 (2002).
  • ••Uses nationally representative data todocument the increased health care utilization and health care costs associated with comorbid depression in adults with diabetes in the USA.
  • Lustman PJ, Griffith LS, Gavard JA, Clouse RE. Depression in adults with diabetes. Diabetes Care 15(11), 1631–1639 (1992).
  • Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of Type 2 diabetes. A prospective population-based study. Diabetes Care 19(10), 1097–1102 (1996).
  • Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of Type 2 diabetes among Japanese men. Diabetes Care 22(7), 1071–1076 (1999).
  • Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function and costs. Anil. Intern Med. 160(21), 3278–3285 (2000).
  • Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23(7), 934–942 (2000).
  • Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depressive symptoms and metabolic control in African-Americans with Type 2 diabetes. Diabetes Care 23(1), 23–29 (2000).
  • de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Ptychosom. Med. 63(4), 619–630 (2001).
  • Hanninen JA, Takala JK, Keinanen- Kiukaanniemi SM. Depression in subjects with Type 2 diabetes. Predictive factors and relation to quality of life. Diabetes Care 22(6), 997–998 (1999).
  • Marcus MD, Wing RR, Guare J, Blair EH, Jawad A. Lifetime prevalence of major depression and its effect on treatment outcome in obese Type 2 diabetic patients. Diabetes Care 15(2), 253–255 (1992).
  • Roy A, Roy M. Depressive symptoms in African-American type 1 diabetics. Depress. Anxiety13(1), 28-31(2001).
  • Wells KB, Hays RD, Burnam MA, Rogers W, Greenfield S, Ware JE Jr. Detection of depressive disorder for patients receiving prepaid or fee- for-service care. Results from the Medical Outcomes Study. JAMA 262 (23), 3298–3302 (1989).
  • Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis and treatment of depression.j Gen. Intern. Med. 14(9), 569–580 (1999).
  • ••Provides detailed information on barriersto recognition and treatment of depression in primary care settings.
  • Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med. Care 30(1), 67–76 (1992).
  • Schulberg HC, Block MR, Madonia MJ etal The usual care of major depression in primary care practice. Anil. Fain. Med. 6(4), 334–339 (1997).
  • Simon GE, Lin EH, Katon W eta]. Outcomes of inadequate antidepressant treatment. J. Gen. Intern. Med. 10(12), 663–670 (1995).
  • Harris MI. Medical care for patients with diabetes. Epidemiologic aspects. Ann. Intern. Med. 124(1 Pt 2), 117–122 (1996).
  • Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. The economic costs of noninsulin-dependent diabetes mellitus. JAMA 262(19), 2708–2713 (1989).
  • Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood) 20(6), 233–241 (2001).
  • American Diabetes Association. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care21, 296–309 (1998).
  • American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 26,917–932 (2003).
  • •Most recent estimate of the direct and indirect costs of diabetes in the USA.
  • Jonsson B. Revealing the cost of Type 2 diabetes in Europe. Diabetologia. 45(7), S5—S12 (2002).
  • •Estimates of the cost of diabetes in Europe. 42Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990.1 Clin. Psychiatry 54(11), 405–418 (1993).
  • Bert° P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo E Depression: cost-of-illness studies in the international literature, a review. J. Men. Health Polity Econ. 3(1), 3–10 (2000).
  • Druss BG, Rosenheck RA. Patterns of healthcare costs associated with depression and substance abuse in a national sample. Ptychiatr Serv. 50(2), 214–218 (1999).
  • Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major US corporation. Arm J. Ptychiatry157(8), 1274–1278 (2000).
  • Average cost of antidepressants for a typical diagnosis and dosing schedule, United States 2001. The National Institute of Healthcare Management Research and Educational Foundation, Washington DC, USA (2001).
  • Finkelstein EA, Bray JW, Chen H et al Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26(2), 415–420 (2003).
  • United Kingdom Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia. 34(12), 877–890 (1991).
  • United Kingdom Prospective Diabetes Study Group. Intensive blood—glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131), 837–853 (1998).
  • Gray A, Raikou M, McGuire A et al Cost effectiveness of an intensive blood glucose control policy in patients with Type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. Brit. Med 320(7246), 1373–1378 (2000). Si The CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control and serum cholesterol level reduction for Type 2 diabetes. JAIVIA 287(19), 2542–2551 (2002).
  • Lave JR, Frank RG, Schulberg HC, Kamlet MS. Cost-effectiveness of treatments for major depression in primary care practice. Azrh. Cen. Psychiatry55(7), 645–651 (1998).
  • Forder J, Kavanagh S, Fenyo A. A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care. J. Affect. Disord 38(2–3), 97-111(1996).
  • Simon GE, VonKorff M, Heiligenstein JH etal Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine verses tricyclic antidepressants. JAIVIA 275(24), 1897–1902 (1996).
  • Revicki DA, Brown RE, Keller MB, Gonzales J, Culpepper L, Hales RE. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings. J. Gun. Psychiatry 58(2), 47–58 (1997).
  • Panzarino PJ, Jr., Nash DB. Cost-effective treatment of depression with selective serotonin reuptake inhibitors. Am.J.Manag. Care7 (2), 173–184 (2001).
  • Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann. Gun. PFhiatry13(1), 31–41 (2001).
  • •Reviews the metabolic effects of antidepressants in individuals with diabetes.
  • Lustman PJ, Griffith LS, Clouse RE et al Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom. Med. 59(3), 241–250 (1997).
  • Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in Type 2 diabetes mellitus. A randomized, controlled trial. Ann. Intern. Med. 129(8), 613–621 (1998) .
  • Snow V, Lascher S, Mottur-Pilson C. Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians-American Society of Internal Medicine. Ann. Intern. Merl 132(9), 738–742 (2000).
  • •Evidence review of pharrnacologic treatments for acute major depression.
  • Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J. Gun. Bychiatry 56 (4), 128–136 (1995).
  • Frank E, Prien RF, Jarrett RB etal Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse and recurrence. Airh. Gen. Fiychiatry48(9), 851–855 (1991).
  • •Review of definition of important terms in treatment of major depression.
  • Schulberg HC, Katon W, Simon GE, Rush AJ. Treating major depression in primary care practice: an update of the Agency for Healthcare Policy and Research Practice Guidelines. Arch. Gen. PFhiatry55(12), 1121–1127 (1998).
  • ••Update on treatment guidelines fordepression in primary care settings.
  • Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Mlbank Q. 74(4), 511–544 (1996).
  • Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAIVIA 288 (14), 1775–1779 (2002).
  • •Review of the chronic disease model of care.
  • Von Korff M, Katon W Unutzer J, Wells K, Wagner EH. Improving depression care: barriers, solutions and research needs. J. Fain. Pratt 50 (6), E 1 (2001) .
  • US Preventive Services Task Force. Screening for depression: recommendations and rationale. Ann. Intern. Med. 136(10), 760–764 (2002).
  • Egede LE. Beliefs and attitudes of African- Americans with Type 2 diabetes toward depression. Diabetes Blur. 28(2), 258–268 (2002).
  • Palinkas LA, Barrett-Connor E, Wingard DL. Type 2 diabetes and depressive symptoms in older adults: a population-based study. Dabet. Med 8(6), 532–539 (1991).
  • Macrodimitris SD, Endler NS. Coping, control and adjustment in Type 2 diabetes. Health P9rhol. 20(3), 208–216 (2001).
  • Peveler R, Carson A, Rodin G. Depression in medical patients. Brit. Med J. 325(7356), 149–152 (2002).

Websites

  • Center for Disease Control and Prevention. Diabetes surveillance, 1999. US Department of Health and Human Services, Public Health Service, CDC, Atlanta, Georgia, USA, (1999). Available from: www.cdc.gov/diabetes/statistics/ surv199/index.htm (Accessed March 14,2003).
  • National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics fact sheet: general information and national estimates on diabetes in the United States, 2000. US Department of Health and Human Services, National Institutes of Health, Bethesda, MD, USA (2002). www.niddk.nih.gov/health/diabetes/pubs/ dmstats/dmstats.htm (Accessed March 14,2003).
  • •Detailed information about epidemiology, complications, and costs of diabetes in the USA.
  • Summary: the global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Murray CJL, Lopez AD. (Eds). Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Harvard University Press, Cambridge, MA, USA, (1996). www.who.int/msa/mnh/ems/dalys/ intro.htm (Accessed March 14,2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.